Cardionet Inc  

(Public, NASDAQ:BEAT)   Watch this stock  
Find more results for beat
2.77
-0.06 (-2.12%)
May 17 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 2.75 - 2.92
52 week 1.84 - 3.00
Open 2.87
Vol / Avg. 36,688.00/55,777.00
Mkt cap 70.02M
P/E     -
Div/yield     -
EPS -0.43
Shares 25.28M
Beta 0.44
Inst. own 65%
Aug 7, 2013
Q2 2013 CardioNet, Inc. Earnings Release Add to calendar
May 10, 2013
Q1 2013 CardioNet, Inc. Earnings Release
Apr 23, 2013
Q1 2013 CardioNet, Inc. Earnings Conference Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '13) 2012
Net profit margin -6.44% -10.94%
Operating margin -6.27% -11.80%
EBITD margin - 2.02%
Return on average assets -9.35% -13.19%
Return on average equity -12.06% -16.49%
Employees 728 -
Carbon Disclosure Rating - -

Address

#210 227 Washington Street
CONSHOHOCKEN, PA 19428
United States - Map
+1-610-7297000 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

CardioNet, Inc. provides continuous, real-time ambulatory outpatient management solutions for monitoring clinical information regarding an individual's health. It operates in two segments: Patient service and products. The patient service business segment's principal focus is on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders, through its core Mobile Cardiac Outpatient Telemetry (MCOT), event and Holter services. The product business segment focuses on the development, manufacturing, testing and marketing of medical devices and related software to medical companies, clinics and hospitals. It has developed an integrated patient management platform that incorporates a wireless data transmission network, internally developed software, Food and Drug Administration (FDA) cleared algorithms and medical devices, and an around-the-clock digital monitoring service center. In February 2012, it acquired ECG Scanning & Medical Services, Inc.

Officers and directors

Kirk E. Gorman Independent Chairman of the Board
Age: 62
Bio & Compensation  - Reuters
Joseph H. Capper President, Chief Executive Officer, Director
Age: 48
Bio & Compensation  - Reuters
Heather C. Getz CPA Chief Financial Officer, Senior Vice President
Age: 37
Bio & Compensation  - Reuters
Peter Ferola Senior Vice President - Corporate Development, General Counsel
Age: 43
Bio & Compensation  - Reuters
Anthony Schuler Senior Vice President - Sales
Age: 40
Bio & Compensation  - Reuters
George Hrenko Senior Vice President - Human Resources, Organizational Excellence
Age: 49
Bio & Compensation  - Reuters
Michael Geldart Senior Vice President - Corporate Strategy and Business Development
Age: 44
Bio & Compensation  - Reuters
Anna McNamara Senior Vice President - Clinical Operations
Age: 64
Bio & Compensation  - Reuters
Daniel Wisniewski Senior Vice President - Business Operations
Age: 48
Bio & Compensation  - Reuters
Ronald A. Ahrens Lead Independent Director
Age: 72
Bio & Compensation  - Reuters